[Research progress of neutrophil extracellular traps in septic coagulopathy]

Zhuowen Dai1, Qiong Wang2

  • 1Department of Laboratory Medicine, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi 214023, China.

Insights

Neutrophil extracellular traps (NETs) drive sepsis-induced coagulopathy (SIC) by damaging blood vessels and disrupting clotting. Targeting NETs may offer new diagnostic and therapeutic strategies for this critical condition.

Area of Science:

  • Critical care medicine
  • Hematology
  • Immunology

Background:

  • Sepsis-induced coagulopathy (SIC) is a severe complication in intensive care, linked to high mortality.
  • Vascular endothelial cell injury and coagulation dysfunction are key pathological mechanisms in sepsis.
  • Neutrophil extracellular traps (NETs) are implicated in various inflammatory and infectious diseases.

Purpose of the Study:

  • To review the mechanistic role of NETs in the pathogenesis of SIC.
  • To discuss the potential of NETs as diagnostic biomarkers for SIC.
  • To explore NETs as therapeutic targets for managing SIC.

Main Methods:

  • Literature review of studies investigating NETs and SIC.
  • Analysis of mechanisms linking NETs to endothelial damage and coagulation imbalance.
  • Synthesis of current research on NET-based diagnostics and therapeutics.

Main Results:

  • NETs contribute to SIC by causing vascular damage and promoting immunothrombosis.
  • NETs disrupt the balance between coagulation and fibrinolysis in sepsis.
  • Evidence suggests NETs play a central role in SIC development.

Conclusions:

  • NETs are crucial mediators in the development of sepsis-induced coagulopathy.
  • NETs show promise as potential biomarkers for early diagnosis of SIC.
  • Targeting NETs represents a potential therapeutic strategy for SIC.

Related Concept Videos